One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often than commonly thought, clinical trials are also uninformative.1 Artificial ...

Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals all have important ongoing clinical trials. Shares of these ...

From insulin to immunotherapies, clinical trials have powered some of the most important medical breakthroughs of our time.

Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO) saw its stock increase by 7.4% after revealing a new clinical study collaboration with AGEPHA Pharma focused on treating inflammation-driven coronary ...

In the first randomized clinical trial of remote pulmonary artery pressure–guided monitoring and management of chronic heart failure (HF) in Europe, the intervention "substantially" improved ...

Aktiia, a pioneer in continuous blood pressure monitoring, has secured FDA 510(k) clearance for its medical-grade G0 Blood ...

Invivyd, Inc. announced the publication of results from its CANOPY Phase 3 clinical trial of pemivibart, a monoclonal antibody aimed at preventing symptomatic COVID-19. This trial, unique for its ...

Abivax SA (NASDAQ:ABVX) shares surged in post-market trading Tuesday after the French biotech firm announced successful Phase 3 trial results for its ulcerative colitis treatment, obefazimod. The oral ...